Dynarx Technology

Bengaluru, India Founded: 2006 • Age: 20 yrs
Manufactures iodine derivatives and specialty chemicals for pharmaceutical and biotech sectors.

About Dynarx Technology

Dynarx Technology is a Healthcare company based in Bengaluru (India) founded in 2006. It manufactures iodine derivatives and specialty chemicals for pharmaceutical and biotech sectors. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 123 employees. Its Indian entity Dynarx Technology (India) Limited reported revenue of β‚Ή65.35 Cr. Dynarx Technology offers products and services including Iodine Derivatives, Speciality Chemicals, API Intermediates, and Products-Under Development. Its focus areas include Pharmaceutical Tech, API Manufacturing, Biotech Solutions and Chemicals. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.

Company details

Dynarx Technology India Limited produces iodine derivatives, specialty chemicals, and API intermediates, focusing on high-quality manufacturing processes. Based in Karnataka, India, they supply cost-effective solutions to pharmaceutical and biotech industries through rigorous quality control and sustainable practices. The company emphasizes innovation and reliable partnerships to meet global demands.

  • Headquarters Bengaluru, India
  • Employees 123
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website dynarx.com
  • Social LinkedIn X Facebook
  • Legal Name Dynarx Technology (India) Limited
  • Date of Incorporation 13 Feb, 1996
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹65.35 Cr

    FY 2024 · +10% YoY

  • Net Profit
    ₹1.27 Cr

    FY 2024 · 2% margin

  • EBITDA
    ₹7.17 Cr

    FY 2024 · 11% margin

  • Employee Count
    123

Products & Services of Dynarx Technology

Dynarx Technology offers a comprehensive portfolio of products and services, including Iodine Derivatives, Speciality Chemicals, API Intermediates, and Products-Under Development.

Iodine Derivatives
Chemical Products

Range of iodine-based chemicals for industrial applications

Speciality Chemicals
Pharma Intermediates

Solutions for pharmaceutical and biotech manufacturing processes

API Intermediates
Active Ingredients

Intermediates for drug production and radio contrast agents

Products-Under Development
Innovation

Emerging chemicals for future pharmaceutical needs

Board of directors of Dynarx Technology (India) Limited (Dynarx Technology)

Dynarx Technology (India) Limited is the primary company behind Dynarx Technology. The board of Dynarx Technology (India) Limited currently have 3 directors; the longest-serving is Kaparthy Narayanamurthy Abhilash, appointed in 1996. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kaparthy Narayanamurthy Abhilash
DIN 01440669
Managing Director13 Feb 199630 yrs 9 moDynarx Technology (India) Limited
Chaitra
DIN 03130537
Whole-time director09 Jul 201016 yrs 4 moDynarx Technology (India) Limited
Sankar Venkitachalam Iyer
DIN 03500488
Whole-time director09 May 201214 yrs 6 moDynarx Technology (India) Limited

Financials of Dynarx Technology

Figures of Dynarx Technology (India) Limited, the primary company behind Dynarx Technology, for FY 2024. Revenue was ₹65.35 Cr (+10% year on year). Net profit was ₹1.27 Cr (2% margin). EBITDA was ₹7.17 Cr (11% margin). Revenue has grown at a compounded annual rate of +16% over three years and +26% over five years.

  • ₹65.35 CrRevenue · FY 2024 · +10% YoY
  • ₹1.27 CrNet profit · 2% margin
  • ₹7.17 CrEBITDA · 11% margin
  • ₹2.94 CrPaid-up capital
  • 123Employees (provident fund records)
  • +16%Revenue CAGR, 3 years
  • +26%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Dynarx Technology (India) Limited are on its company page.

Premium access

Detailed financial statements for Dynarx Technology

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Dynarx Technology

Dynarx Technology has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viyash.com2019Hyderabad, India$120.02M277
APIs and intermediates are manufactured by Viyash as a CDMO.
inventys.in2005Mumbai, India$64.34M219
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
bluejethealthcare.com1969Mumbai, India476
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
Premium access

Detailed competitors of Dynarx Technology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dynarx Technology

Dynarx Technology was founded in 2006.

Dynarx Technology is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Dynarx Technology has 123 employees.

The primary company behind Dynarx Technology, Dynarx Technology (India) Limited, reported revenue of β‚Ή65.35 Cr for FY 2024, up 10% year on year.

Dynarx Technology India Limited produces iodine derivatives, specialty chemicals, and API intermediates, focusing on high-quality manufacturing processes. Based in Karnataka, India, they supply cost-effective solutions to pharmaceutical and biotech industries through rigorous quality control and sustainable practices. The company emphasizes innovation and reliable partnerships to meet global demands.

Dynarx Technology's top competitors include Inventys, Viyash and Blue Jet Healthcare.

Dynarx Technology offers Iodine Derivatives, Speciality Chemicals, API Intermediates, and Products-Under Development.

Dynarx Technology operates through Dynarx Technology (India) Limited.

The legal entities of Dynarx Technology currently have 3 directors, including Chaitra, Sankar Venkitachalam Iyer, Kaparthy Narayanamurthy Abhilash.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available